3 Stocks To Beat The FTSE 100: Unilever plc, AstraZeneca plc And British American Tobacco plc

These 3 shares could outperform the wider index: Unilever plc (LON: ULVR), AstraZeneca plc (LON: AZN) and British American Tobacco plc (LON: BATS)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

FTSE100

Over the last month, the FTSE 100 has fallen by 4.5%. This is a significant fall in a short period of time and shows that, while the global economy may be moving in the right direction, stock market corrections are a very real threat to investors.

Indeed, recent weeks have seen the FTSE 100 become much more volatile, with 50+ points being added/removed from the index on a daily basis.

Should you invest £1,000 in Bodycote Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Bodycote Plc made the list?

See the 6 stocks

With this in mind, here are three stocks that not only have bright futures and trade at attractive prices, but also offer relative stability during a highly uncertain period. As a result, they could beat the FTSE 100 moving forward.

Unilever

One of the key attractions of Unilever (LSE: ULVR) (NYSE: UL.US) is its sheer diversity. Of course, that’s not only in regard to its global footprint, with Unilever operating in all corners of the world, but also with a view to its wide range of brands.

Indeed, it sells all manner of consumer goods: from margarine to shampoo. As a result, it tends to offer relatively stable top- and bottom-line numbers that could prove to be major assets during uncertain economic periods.

Furthermore, Unilever has considerable growth potential. With around 60% of its revenue being derived from emerging markets, it should beat the index average when it comes to bottom line growth and, in addition, its current price to earnings (P/E) ratio of 19.8 is low by historical standards.

AstraZeneca

Clearly, the performance of a pharmaceutical company is less dependent upon the performance of the wider economy. So, it’s of little surprise that AstraZeneca (LSE: AZN) (NYSE: AZN.US) is classed as a defensive stock.

However, there’s much more to the company than just a defensive play. Certainly, its pipeline has disappointed in recent years but, after numerous acquisitions, it now has huge potential. For example, the purchase of Bristol-Myers Squibb’s share of the diabetes joint venture could prove to be a masterstroke as the number of diabetes cases worldwide is expected to increase at a rapid rate.

Despite this potential, AstraZeneca trades on a P/E ratio of just 16. While higher than the wider market, this valuation remains relatively attractive when compared to its sector rivals.

British American Tobacco

With tobacco sales being very consistent, British American Tobacco (LSE: BATS) is a great place to invest when the outlook is uncertain for the wider stock market. Indeed, with a beta of just 0.8, British American Tobacco should provide a relatively less volatile experience moving forward.

However, with considerable growth potential in its e-cigarette subsidiary, Nicoventures, British American Tobacco could prove to be more than just a defensive play. Furthermore, with a yield of 4.2% and a long track record of strong dividend growth, it could marry income and reliable growth to provide a potent combination.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca, British American Tobacco and Unilever. The Motley Fool UK owns shares of Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man thinking about artificial intelligence investing algorithms
Investing Articles

2 FTSE 250 shares I’ll consider piling into if the stock market crashes!

Discover which cheap UK shares and investment trusts our writer Royston Wild will consider buying if the FTSE 250 slumps.

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Near $200, might Palantir stock become the next Microsoft?

This writer is wondering if he should buy Palantir stock, just in case the AI firm goes on to become…

Read more »

Rolls-Royce engineer working on an engine
Investing Articles

The hidden risks behind the Rolls-Royce share price rally (and why they may not matter)

The Rolls-Royce share price has soared in recent months but beneath the optimism, several hidden risks could threaten future growth.

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Starting with £100k, how long would it take to build a million-pound SIPP?

Harvey Jones shows how long it would take an investor to build a SIPP or ISA worth a cool £1m,…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

Prediction: in 12 months Shell and BP shares could turn £10k into…

Harvey Jones says BP shares have had a rotten run but there are signs they are starting to climb. Can…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

£10,000 invested in Aviva shares at the start of 2025 is now worth…

We've been told that 'elephants don't gallop'. But someone forgot to tell Aviva shares! Paul Summers looks at just how…

Read more »

Investing Articles

Rolls-Royce could become the largest company on the London Stock Exchange, according to CEO Tufan Erginbilgiç

Rolls-Royce is currently the sixth-biggest company on the London Stock Exchange. However, CEO Tufan Erginbilgiç believes that one day it…

Read more »

Black woman using smartphone at home, watching stock charts.
US Stock

Here are the latest forecasts for Tesla stock

Jon Smith takes a look at Tesla stock predictions from some of the main banks and brokers and tries to…

Read more »